Invacare closes China factory

Tuesday, June 27, 2017

ELYRIA, Ohio – Invacare has closed its Suzhou, China manufacturing facility it announced June 26. The change is in line with the company’s strategic plan to leverage its infrastructure and improve efficiencies. The closure is expected to generate $4 million in pre-tax savings annually. “We are focused on having the right number of facilities in the right locations to better meet the needs of our customers,” said Matthew Monaghan, chairman, president and CEO in a release. Since taking the helm in 2015, Monaghan has worked to turn around the North America HME business. Since 2012, Invacare has been under a consent decree with the U.S. Food and Drug Administration that has limited its ability to make and sell certain products from its corporate headquarters and Taylor Street manufacturing facility. The company announced recently that the FDA has now approved three certification reports from its third-party auditor and it is now waiting for the agency to re-inspect its facilities.